Fabry Disease Treatment Market

The global Fabry Disease Treatment market was valued at US$ 1576.6 million in 2022 and is projected to reach US$ 2243.3 million by 2029, at a CAGR of 5.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
Fabry Disease Treatment Market aims to provide a comprehensive presentation of the global market for Fabry Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fabry Disease Treatment. Fabry Disease Treatment Market contains market size and forecasts of Fabry Disease Treatment in global, including the following market information:

• Global Fabry Disease Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global top five companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Enzyme Replacement Therapy (ERT) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fabry Disease Treatment include Sanofi S.A., Takeda, Amicus Therapeutics Inc., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Protalix Biotherapeutics Inc., Idorsia Pharmaceuticals Ltd., Avrobio Inc. and Greenovation Biotech GmbH, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fabry Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fabry Disease Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Fabry Disease Treatment Market Segment Percentages, by Type, 2022 (%)

• Enzyme Replacement Therapy (ERT)
• Chaperone Treatment
• Substrate Reduction Therapy (SRT)
• Others

Global Fabry Disease Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Fabry Disease Treatment Market Segment Percentages, by Application, 2022 (%)

• Hospital
• Clinic
• Others

Global Fabry Disease Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Fabry Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fabry Disease Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Fabry Disease Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Sanofi S.A.
• Takeda
• Amicus Therapeutics Inc.
• ISU Abxis Co Ltd.
• JCR Pharmaceuticals Co Ltd.
• Protalix Biotherapeutics Inc.
• Idorsia Pharmaceuticals Ltd.
• Avrobio Inc.
• Greenovation Biotech GmbH
• Moderna Therapeutics Inc.
• Green Cross Pharma Pte Ltd.

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Fabry Disease Treatment, market overview.
• Chapter 2: Global Fabry Disease Treatment market size in revenue.
• Chapter 3: Detailed analysis of Fabry Disease Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Fabry Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.

To know more about market statistics, Download a FREE Sample copy